Literature DB >> 28492287

Dyslipidaemia: PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemia.

Huaizhu Wu1, Christie M Ballantyne1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28492287      PMCID： PMC5808934          DOI： 10.1038/nrcardio.2017.75

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans.

Authors:  Sophie J Bernelot Moens; Simone L Verweij; Johan G Schnitzler; Lotte C A Stiekema; Merijn Bos; Anne Langsted; Carlijn Kuijk; Siroon Bekkering; Carlijn Voermans; Hein J Verberne; Børge G Nordestgaard; Erik S G Stroes; Jeffrey Kroon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-23       Impact factor: 8.311

2.  A high-fat meal promotes lipid-load and apolipoprotein B-48 receptor transcriptional activity in circulating monocytes.

Authors:  Lourdes M Varela; Almudena Ortega; Beatriz Bermudez; Sergio Lopez; Yolanda M Pacheco; Jose Villar; Rocio Abia; Francisco J G Muriana
Journal:  Am J Clin Nutr       Date:  2011-03-02       Impact factor: 7.045

3.  Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia.

Authors:  Lu Xu; Xiaoyuan Dai Perrard; Jerry L Perrard; Donglin Yang; Xinhua Xiao; Ba-Bie Teng; Scott I Simon; Christie M Ballantyne; Huaizhu Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-25       Impact factor: 8.311

Review 4.  Effects of dyslipidaemia on monocyte production and function in cardiovascular disease.

Authors:  Mohammed Shamim Rahman; Andrew J Murphy; Kevin J Woollard
Journal:  Nat Rev Cardiol       Date:  2017-03-16       Impact factor: 32.419

5.  Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Authors:  Paul M Ridker; James Revkin; Pierre Amarenco; Robert Brunell; Madelyn Curto; Fernando Civeira; Marcus Flather; Robert J Glynn; Jean Gregoire; J Wouter Jukema; Yuri Karpov; John J P Kastelein; Wolfgang Koenig; Alberto Lorenzatti; Pravin Manga; Urszula Masiukiewicz; Michael Miller; Arend Mosterd; Jan Murin; Jose C Nicolau; Steven Nissen; Piotr Ponikowski; Raul D Santos; Pamela F Schwartz; Handrean Soran; Harvey White; R Scott Wright; Michal Vrablik; Carla Yunis; Charles L Shear; Jean-Claude Tardif
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

6.  Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia.

Authors:  Jacob J Christensen; Liv T Osnes; Bente Halvorsen; Kjetil Retterstøl; Martin P Bogsrud; Cecilie Wium; Arne Svilaas; Ingunn Narverud; Stine M Ulven; Pål Aukrust; Kirsten B Holven
Journal:  Atherosclerosis       Date:  2016-12-01       Impact factor: 5.162

7.  Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Authors:  Marc S Sabatine; Robert P Giugliano; Anthony C Keech; Narimon Honarpour; Stephen D Wiviott; Sabina A Murphy; Julia F Kuder; Huei Wang; Thomas Liu; Scott M Wasserman; Peter S Sever; Terje R Pedersen
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

8.  Postprandial Monocyte Activation in Individuals With Metabolic Syndrome.

Authors:  Ilvira M Khan; Yashashwi Pokharel; Razvan T Dadu; Dorothy E Lewis; Ron C Hoogeveen; Huaizhu Wu; Christie M Ballantyne
Journal:  J Clin Endocrinol Metab       Date:  2016-08-30       Impact factor: 5.958

9.  Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia.

Authors:  Huaizhu Wu; R Michael Gower; Hong Wang; Xiao-Yuan Dai Perrard; Ruidong Ma; Daniel C Bullard; Alan R Burns; Antoni Paul; C Wayne Smith; Scott I Simon; Christie M Ballantyne
Journal:  Circulation       Date:  2009-05-11       Impact factor: 29.690

10.  PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia.

Authors:  Sophie J Bernelot Moens; Annette E Neele; Jeffrey Kroon; Fleur M van der Valk; Jan Van den Bossche; Marten A Hoeksema; Renate M Hoogeveen; Johan G Schnitzler; Marie T Baccara-Dinet; Garen Manvelian; Menno P J de Winther; Erik S G Stroes
Journal:  Eur Heart J       Date:  2017-05-21       Impact factor: 29.983
  10 in total
  6 in total

1.  PRECISION MEDICINE FOR CARDIOVASCULAR DISEASE PREVENTION: WHERE DO WE STAND IN 2019 WITH A FOCUS ON INFLAMMATION AND LIPIDS?

Authors:  Christie M Ballantyne
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

2.  Effects of n-3 fatty acid treatment on monocyte phenotypes in humans with hypertriglyceridemia.

Authors:  Xiao-Yuan Dai Perrard; Zeqin Lian; George Bobotas; Mary R Dicklin; Kevin C Maki; Huaizhu Wu
Journal:  J Clin Lipidol       Date:  2017-08-26       Impact factor: 4.766

3.  Four weeks of spice consumption lowers plasma proinflammatory cytokines and alters the function of monocytes in adults at risk of cardiometabolic disease: secondary outcome analysis in a 3-period, randomized, crossover, controlled feeding trial.

Authors:  Ester S Oh; Kristina S Petersen; Penny M Kris-Etherton; Connie J Rogers
Journal:  Am J Clin Nutr       Date:  2022-01-11       Impact factor: 7.045

4.  PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction.

Authors:  Hua Sun; Ronald M Krauss; Jeffrey T Chang; Ba-Bie Teng
Journal:  J Lipid Res       Date:  2017-11-27       Impact factor: 5.922

5.  Replacing Saturated Fat With Unsaturated Fat in Western Diet Reduces Foamy Monocytes and Atherosclerosis in Male Ldlr-/- Mice.

Authors:  Zeqin Lian; Xiao-Yuan Dai Perrard; Xueying Peng; Joe L Raya; Alfredo A Hernandez; Collin G Johnson; William R Lagor; Henry J Pownall; Ron C Hoogeveen; Scott I Simon; Frank M Sacks; Christie M Ballantyne; Huaizhu Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-10-17       Impact factor: 8.311

6.  Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia.

Authors:  Ming-Ming Liu; Jia Peng; Yuan-Lin Guo; Cheng-Gang Zhu; Na-Qiong Wu; Rui-Xia Xu; Qian Dong; Jian-Jun Li
Journal:  J Transl Med       Date:  2021-12-07       Impact factor: 5.531
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.